Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study. J of Skin [Internet]. 2025 Jan. 13 [cited 2026 May 24];9(1):s515. Available from: https://skin.dermsquared.com/skin/article/view/3149